논문 및 학회자료
|
Safety Evaluation of FM101, an A3 Adenosine Receptor Modulator, in Rat, for Developing as Therapeutics of Glaucoma and Hepatitis. EXCLI Journal. 2020
Admin │ 2020-06-11 HIT 625 |
|---|
| 이전글 | A randomized, double-blind, placebo-controlled, first-in-human single ascending ... |
|---|---|
| 다음글 | Preclinical characterization of FM101, a first-in-class A3 adenosine receptor mo... |